My watch list  

401 Current news of Merck


You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics


Merck announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO). The deal strengthens Merck’s capabilities to develop and manufacture mRNA for its customers for use in vaccines, treatments and diagnostics applicable in ...


image description
Merck Expands Life Science Production Capacities in the United States

Global coronavirus pandemic has significantly increased demand


Merck announced the broadening of its manufacturing footprint with a combined € 40 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, USA. These sites supply critical products to customers developing lifesaving therapies, including Covid-19 ...


image description
Merck and Artios will conduct collaborative research

Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology


Merck and Artios Pharma Limited, a leading DNA Damage Response (DDR) company developing a broad pipeline of precision medicines for the treatment of cancer, announced a global three year strategic research collaboration to discover and develop multiple precision oncology drugs. “Our platform has ...


image description
Digitalization of Production: Merck and Siemens Collaborate

Merck invests € 10 million in modular technical infrastructure


Merck announced a collaborative partnership with Siemens for the digitalization of production. This partnership is to result in the development of a process control system for the modular production of innovative materials and products for the electronics, pharmaceutical and life science ...


image description
Merck Reports Strong Third Quarter

In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion


Merck grew significantly in the third quarter. In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion. The increase was primarily due to double-digit percentage organic growth in the Life Science business sector and acquisition-related increases in the ...


image description
Merck Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test

Once approved, new test will help laboratories increase testing capacity and decrease turnaround time for results


Merck announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, USA, for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test. Mammoth’s high-throughput systems will be compatible with both nasal swab and ...


image description
Merck Awards Grant to Combined Therapeutics for its Nucleic Acid Platform

Platform combined with virotherapy targets cancerous cells while protecting healthy tissue of key organs


Merck announced that Combined Therapeutics Inc., Cambridge, Massachusetts, USA, has been selected as the North American winner of its 2020 Advance Biotech Grant Program. The biotechnology company was selected for its innovative nucleic acid platform which, combined with virotherapy, has the ...


image description
Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant

Investment of more than € 140 million creates approximately 55 new jobs


Merck celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany. With the new facility, the company plans to expand manufacturing of Millipore Express® membranes, which are critical components in Millipore Express® filters and help ensure the sterility of ...


image description
Merck: Stefan Oschmann to Hand Over Chair of Executive Board to Belén Garijo in 2021

Two internationally experienced managers to join Executive Board


Stefan Oschmann will hand over the Chair of the Executive Board of Merck to Belén Garijo in 2021. The Board of Partners of E.MerckKG has appointed Garijo as new Chair of the Executive Board and CEO of Merck effective May 1, 2021. She is currently Vice Chair of the Executive Board and Deputy CEO ...


image description
Merck Well-Positioned for Further Growth

From today’s perspective targeted smaller to medium-sized acquisitions after 2022 more likely than major transformative deals


Merck expects to deliver continued profitable growth in the coming years despite a challenging market environment. Today at its virtual Capital Markets Day, the company presented to analysts and investors the progress made in realizing the growth and expansion phase of its strategy for the period ...


Page 1 From 41
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE